Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1370502
PUBLISHER: IMARC | PRODUCT CODE: 1370502
Ovarian Cancer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
Market Overview:
The global ovarian cancer market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.56% during 2023-2028.
Ovarian cancer refers to a malignant tumor wherein abnormal cells in the ovary begin to multiply and grow uncontrollably from the outer tissue lining or fallopian tubes due to mutagenic changes in the deoxyribonucleic acid (DNA). At present, it can be treated with the support of various diagnoses and drugs, including antirheumatics, antineoplastics, and PARP, mitotic, and VEGF/VEGFR inhibitors. Apart from this, ovarian cancer treatment involves surgery, chemotherapy, hormone, radiation, and targeted therapies that help kill cancer cells to provide relief from signs and systems. These therapeutics are executed by medical practitioners after determining multiple factors, such as the spread of the tumor, individuals' general health, and the size and type of ovarian cancer.
Ovarian Cancer Market Trends:
The increasing prevalence of epithelial, stromal, and germ cell ovarian cancer, especially amongst the female geriatric population, due to the genetic mutation of breast cancer gene 1 (BRCA1) or BRCA2, is primarily driving the market growth. In line with this, the rising need for effective therapeutic drugs, such as bevacizumab (Avastin) and pazopanib (Votrient), is acting as another growth-inducing factor. Additionally, the widespread adoption of combination therapies in the healthcare sector to prevent drug resistance and increase treatment efficacy is supporting the market growth. Moreover, the ongoing patent expiration of branded medications has prompted governments and pharmaceutical companies to launch novel recombinant drugs, which, in turn, is propelling market growth. Furthermore, extensive initiatives undertaken by non-governmental organizations (NGOs) to sensitize consumers regarding the symptoms, treatments, and benefits of early ovarian cancer diagnosis are impelling the market growth. Apart from this, strategic collaborations amongst key players and continuous research and development (R&D) activities to produce efficient therapeutic interventions are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ovarian cancer market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment type and end user.
Breakup by Type:
Epithelial Ovarian Cancer
Germ Cell Ovarian Cancer
Stromal Cell Ovarian Cancer
Breakup by Treatment Type:
Immunotherapy
Chemotherapy
Targeted Therapy
Surgery
Others
Breakup by End User:
Hospitals
Homecare
Speciality Centre
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amneal Pharmaceuticals Inc., AstraZeneca plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GSK plc, Hikma Pharmaceuticals PLC, Lupin Limited, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
- How has the global ovarian cancer market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global ovarian cancer market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global ovarian cancer market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A6407
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Ovarian Cancer Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Epithelial Ovarian Cancer
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Germ Cell Ovarian Cancer
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Stromal Cell Ovarian Cancer
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Treatment Type
- 7.1 Immunotherapy
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Chemotherapy
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Targeted Therapy
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Surgery
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Homecare
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Speciality Centre
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 AbbVie Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Amneal Pharmaceuticals Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 AstraZeneca plc
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Eli Lilly and Company
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 F. Hoffmann-La Roche AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 GSK plc
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Hikma Pharmaceuticals PLC
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Lupin Limited
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Pfizer Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Teva Pharmaceutical Industries Ltd.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 AbbVie Inc.
Product Code: SR112023A6407
List of Figures
- Figure 1: Global: Ovarian Cancer Market: Major Drivers and Challenges
- Figure 2: Global: Ovarian Cancer Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Ovarian Cancer Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Ovarian Cancer Market: Breakup by Type (in %), 2022
- Figure 5: Global: Ovarian Cancer Market: Breakup by Treatment Type (in %), 2022
- Figure 6: Global: Ovarian Cancer Market: Breakup by End User (in %), 2022
- Figure 7: Global: Ovarian Cancer Market: Breakup by Region (in %), 2022
- Figure 8: Global: Ovarian Cancer (Epithelial Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Ovarian Cancer (Epithelial Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Ovarian Cancer (Germ Cell Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Ovarian Cancer (Germ Cell Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Ovarian Cancer (Stromal Cell Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Ovarian Cancer (Stromal Cell Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Ovarian Cancer (Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Ovarian Cancer (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Ovarian Cancer (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Ovarian Cancer (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Ovarian Cancer (Targeted Therapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Ovarian Cancer (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Ovarian Cancer (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Ovarian Cancer (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Ovarian Cancer (Other Treatment Types) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Ovarian Cancer (Other Treatment Types) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Ovarian Cancer (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Ovarian Cancer (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Ovarian Cancer (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Ovarian Cancer (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Ovarian Cancer (Speciality Centre) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Ovarian Cancer (Speciality Centre) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Global: Ovarian Cancer (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Global: Ovarian Cancer (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: North America: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: North America: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: United States: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: United States: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Canada: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Canada: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Asia-Pacific: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Asia-Pacific: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: China: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: China: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: Japan: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: Japan: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: India: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: India: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: South Korea: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: South Korea: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Australia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Australia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Indonesia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Indonesia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Europe: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Europe: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Germany: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Germany: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: France: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: France: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: United Kingdom: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: United Kingdom: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Italy: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Italy: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Spain: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Spain: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Russia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Russia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Latin America: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Latin America: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Brazil: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Brazil: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Mexico: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Mexico: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Middle East and Africa: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Middle East and Africa: Ovarian Cancer Market: Breakup by Country (in %), 2022
- Figure 80: Middle East and Africa: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Global: Ovarian Cancer Industry: SWOT Analysis
- Figure 82: Global: Ovarian Cancer Industry: Value Chain Analysis
- Figure 83: Global: Ovarian Cancer Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Ovarian Cancer Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Ovarian Cancer Market Forecast: Breakup by Type (in Million US$), 2023-2028
- Table 3: Global: Ovarian Cancer Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
- Table 4: Global: Ovarian Cancer Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 5: Global: Ovarian Cancer Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Ovarian Cancer Market: Competitive Structure
- Table 7: Global: Ovarian Cancer Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.